Genital Diseases, Female  >>  Camtobell (belotecan)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Camtobell (belotecan) / Equisnzaroo
NCT01630018: Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial

Completed
2b
141
RoW
Topotecan, Hycamtin inj., Belotecan, Camtobell inj.
Chong Kun Dang Pharmaceutical
Epithelial Ovarian Cancer
06/14
06/14
NCT00430144: Belotecan (CKD-602) in Recurrent or Progressive Carcinoma of Uterine Cervix

Completed
2
16
RoW
Belotecan(CKD-602), Camptobel
Sokbom Kang
Cervical Cancer
08/09
10/10

Download Options